Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-07-08FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2016-06-24FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin R (insulin human) from Eli Lilly and Company. The approval is a supplemental submission …
-
FDA approval · 2016-06-17FDA Approved: BASAGLAR KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approves a supplemental application for BASAGLAR KWIKPEN (insulin glargine) by Eli Lilly and Company.
-
FDA approval · 2016-04-22FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company. This document indicates a supplemental…
-
FDA approval · 2016-04-13FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine) submitted by Sanofi‑Aventis U.S. LLC, authorizing changes…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-02-26FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN R (insulin human) from Eli Lilly and Company.
-
FDA approval · 2016-02-19FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly.
-
FDA approval · 2016-02-17FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
The FDA approved a supplemental application for AFREZZA (insulin human) from Mannkind Corporation.
-
FDA approval · 2016-01-08FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN R (human insulin) submitted by Novo Nordisk. The action represents regulatory approv…
-
FDA approval · 2016-01-08FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN 70/30 (human insulin) from Novo Nordisk.
-
FDA approval · 2015-12-29FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
FDA approves a supplemental application for HUMULIN R (insulin human) from Eli Lilly and Company.
-
FDA approval · 2015-12-01FDA Approved: GLUCAGON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Glucagon from Fresenius Kabi USA, LLC.
-
FDA approval · 2015-12-01FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for Novo Nordisk's NOVOLIN R (human insulin).
-
FDA approval · 2015-11-03FDA Approved: GLUCAGON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Glucagon submitted by Fresenius Kabi USA, LLC.
-
FDA approval · 2015-10-20FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company.
-
FDA approval · 2015-10-08FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company.
-
FDA approval · 2015-10-08FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN R (insulin human) from Eli Lilly and Company.
-
FDA approval · 2015-09-10FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA has granted a supplemental approval for insulin lispro submitted by Eli Lilly and Company.
-
FDA approval · 2015-07-15FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly and Company.
-
FDA approval · 2015-06-24FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
The FDA approved a supplemental application for Afrezza (insulin human) from MannKind Corporation. This approval updates the label/indicatio…
-
FDA approval · 2015-06-11FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly (Humalog). This action typically relates to labeling changes o…
-
FDA approval · 2015-05-08FDA Approved: GLUCAGON — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA, LLC's original application for Glucagon, approving a new source of glucagon for use in treating severe hypo…
-
FDA approval · 2015-04-17FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NovoLog (insulin aspart) submitted by Novo Nordisk.
-
FDA approval · 2015-04-17FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
The FDA approved a supplemental application for Insulin aspart protamine and insulin aspart mix 70/30 from Novo Nordisk Pharma, Inc., confir…
-
FDA approval · 2015-03-13FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA has approved a supplemental application for insulin lispro submitted by Eli Lilly, indicating an updated approval/label modification for…